Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
miércoles, septiembre 23
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Jaguar Health Inc
JAGX
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$34.46
31.79
1190.64%
al cierre: Sep 22, 5:00 PM EST
$36.25
1.79
5.19%
After hour: 7:59 PM EST
Get Report
PRO
¿Por qué se mueve?:
Jaguar Health shares are trading higher after the company announced that th...
División de acciones:
Se espera que Jaguar Health Inc se divida Thursday, September 17, 2026 con una proporción de 1:15
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
Jaguar Health Financials
Jaguar Health (JAGX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Jaguar Health Q2 EPS $(15.70) Up From $(358.94) YoY, Sales $1.225M Down From $2.979M YoY
Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(15.70) per share. This is a 95.63 percent increase over losses of $(358.94) per share from the same period last year. The company reported $1.225 million in
Benzinga Newsdesk
PRO
Jaguar Health Q1 EPS $(13.60) Misses $(4.26) Estimate, Sales $20.272M Beat $4.211M Estimate
Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(13.60) per share which missed the analyst consensus estimate of $(4.26) by 219.25 percent. This is a 97.67 percent increase over losses of $(584.45) per share
Benzinga Newsdesk
PRO
Jaguar Health Q3 EPS $(6.28) Misses $(5.08) Estimate, Sales $3.083M Miss $3.730M Estimate
Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(6.28) per share which missed the analyst consensus estimate of $(5.08) by 23.62 percent. This is a 76.08 percent increase over losses of $(26.25) per share from
Benzinga Newsdesk
PRO
Jaguar Health Q2 2025 EPS $(10.25) Misses $(7.13) Estimate, Sales $2.979M Miss $3.265M Estimate
Benzinga Newsdesk
Earnings Scheduled For August 14, 2025
Benzinga Insights
Earnings Preview For Jaguar Health
Benzinga Insights
Privacy Manager